Xiao et al. reported that eleven genes, including ERBB2, PIK3CA, AKT1, and ESR1, were more frequently associated with mutations or gene amplifications in younger breast cancer patients (≤35 years) [39]. This evidence concerns the gene ESR1 and breast carcinoma.